CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 57 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $86,124 | -70.1% | 71,770 | -70.8% | 0.00% | – |
| Q1 2023 | $287,847 | +1632.3% | 246,023 | +1069.7% | 0.00% | – |
| Q4 2022 | $16,616 | -55.1% | 21,033 | -31.3% | 0.00% | – |
| Q3 2022 | $37,000 | -41.3% | 30,615 | -25.3% | 0.00% | – |
| Q4 2021 | $63,000 | +21.2% | 40,984 | +60.1% | 0.00% | – |
| Q3 2021 | $52,000 | -47.5% | 25,600 | -53.8% | 0.00% | – |
| Q1 2021 | $99,000 | +800.0% | 55,361 | +408.8% | 0.00% | – |
| Q4 2019 | $11,000 | – | 10,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |